SKINVIVE by JUVÉDERM, Allergan's hyaluronic acid microdroplet injectable, has received FDA clearance for treatment of neck lines and skin laxity. The formulation is designed to improve skin quality through hydration and subtle volumization rather than traditional bolus filler placement. The mechanism relies on precise microdroplet distribution to stimulate collagen remodeling and improve skin elasticity.
Regulatory
SKINVIVE by JUVÉDERM Gains FDA Approval for Neck Lines—New Indication Expands Filler Market
Allergan's hyaluronic acid microdroplet formulation clears for neck laxity, opening a new anatomical revenue stream for practices.

1-YEAR MOVE
ABBV
▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |